• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PCR for HBV, HCV and HIV-1 experiences and first results from a routine screening programme in a large blood transfusion service.

作者信息

Schottstedt V, Tuma W, Bünger G, Lefèvre H

机构信息

Red Cross Blood Transfusion Service North-Rhine Westfalia, Germany.

出版信息

Biologicals. 1998 Jun;26(2):101-4. doi: 10.1006/biol.1998.0144.

DOI:10.1006/biol.1998.0144
PMID:9811513
Abstract

We adapted the PCR method to screen up to 3000 blood donations per day for hepatitis B, hepatitis C and HIV-1 virus contamination. Up to 600 aliquots (average 418 donations) are pooled by using an automatic sample processor with disposable tips (validated to avoid contamination) taken from blood donations which are serologically negative and free for clinical usage according to federal regulations. In the case of a positive PCR pool result the viraemic donation is identified by two additional PCR pools testing steps with smaller pool sizes. All of the steps are supported by electronic data processing. After virus concentration by ultracentrifugation, and in the case of HCV and HIV-1 an additional reverse transcription step, PCR amplifications are performed. PCRs are done for each virus in two genomic regions. Laser-induced detection after PAGE and computer-analysis are used to identify the amplification products. Using this validated methodology routine we have checked 428 896 donations up to the end of August 1996. During this survey we found at least 24 viruses-containing donations which were negative in corresponding serological tests and would have been transfused (2 HBV-, 22 HCV-, 0 HIV-1 -containing donations). It seems possible for large transfusion centres to shorten the diagnostic window periods with our PCR-methodology with acceptable costs (15 DM per donation for all three viruses including logistics, developments and investments).

摘要

相似文献

1
PCR for HBV, HCV and HIV-1 experiences and first results from a routine screening programme in a large blood transfusion service.
Biologicals. 1998 Jun;26(2):101-4. doi: 10.1006/biol.1998.0144.
2
[Routine PCR screening for HBV, HCV and HIV-I genome in a large blood donation services--experiences and initial results].[在大型献血服务中对乙肝病毒、丙肝病毒和艾滋病毒-1基因组进行常规聚合酶链反应筛查——经验与初步结果]
Beitr Infusionsther Transfusionsmed. 1997;34:21-5.
3
Feasibility and efficacy of routine PCR screening of blood donations for hepatitis C virus, hepatitis B virus, and HIV-1 in a blood-bank setting.在血库环境中对献血者进行丙型肝炎病毒、乙型肝炎病毒和HIV-1常规PCR筛查的可行性和有效性。
Lancet. 1999 Jan 30;353(9150):359-63. doi: 10.1016/S0140-6736(98)06318-1.
4
[Detection of the nucleic acids of hepatitis B and C viruses and human immunodeficiency virus for the biological screening of blood donations. Viral Hepatitis and Retrovirus Working Groups and Subgroup for Molecular Biology Applied to Transfusion Virology of the French Blood Transfusion Society].[用于献血者生物学筛查的乙型和丙型肝炎病毒及人类免疫缺陷病毒核酸检测。法国输血协会病毒性肝炎和逆转录病毒工作组及应用于输血病毒学的分子生物学小组]
Transfus Clin Biol. 1998 Apr;5(2):139-46. doi: 10.1016/s1246-7820(98)80004-9.
5
High throughput screening of 16 million serologically negative blood donors for hepatitis B virus, hepatitis C virus and human immunodeficiency virus type-1 by nucleic acid amplification testing with specific and sensitive multiplex reagent in Japan.在日本,使用特异性和灵敏性兼具的多重试剂通过核酸扩增检测对1600万血清学阴性献血者进行乙型肝炎病毒、丙型肝炎病毒和1型人类免疫缺陷病毒的高通量筛查。
J Virol Methods. 2003 Sep;112(1-2):145-51. doi: 10.1016/s0166-0934(03)00215-5.
6
Mathematic modeling of the risk of HBV, HCV, and HIV transmission by window-phase donations not detected by NAT.核酸检测未检出的窗口期献血导致乙肝病毒、丙肝病毒和艾滋病毒传播风险的数学模型
Transfusion. 2002 May;42(5):537-48. doi: 10.1046/j.1537-2995.2002.00099.x.
7
The first large-scale nucleic acid amplification testing (NAT) of donated blood using multiplex reagent for simultaneous detection of HBV, HCV, and HIV-1 and significance of NAT for HBV.使用多重试剂同时检测HBV、HCV和HIV-1对献血进行的首次大规模核酸扩增检测(NAT)以及NAT对HBV的意义
Microbiol Immunol. 2001;45(9):667-72. doi: 10.1111/j.1348-0421.2001.tb01300.x.
8
[Safe blood in the absence of viral infections due to HBV, HCV and HIV in serological window period in donors].[献血者血清学窗口期内无乙肝病毒(HBV)、丙肝病毒(HCV)和艾滋病毒(HIV)感染的安全血液]
Salud Publica Mex. 2011;53 Suppl 1:S13-8.
9
Analytical and clinical sensitivity of the Procleix Ultrio HIV-1/HCV/HBV assay in samples with a low viral load.Procleix Ultrio HIV-1/HCV/HBV检测法对低病毒载量样本的分析灵敏度和临床灵敏度
Vox Sang. 2007 Jan;92(1):8-14. doi: 10.1111/j.1423-0410.2006.00857.x.
10
Automated multiplex assay system for simultaneous detection of hepatitis B virus DNA, hepatitis C virus RNA, and human immunodeficiency virus type 1 RNA.用于同时检测乙型肝炎病毒DNA、丙型肝炎病毒RNA和1型人类免疫缺陷病毒RNA的自动化多重检测系统。
J Clin Microbiol. 2001 Aug;39(8):2937-45. doi: 10.1128/JCM.39.8.2937-2945.2001.

引用本文的文献

1
History and Future of Nucleic Acid Amplification Technology Blood Donor Testing.核酸扩增技术用于献血者检测的历史与未来
Transfus Med Hemother. 2019 Apr;46(2):67-75. doi: 10.1159/000496749. Epub 2019 Feb 5.
2
Safety and availability of immunoglobulin replacement therapy in relation to potentially transmissable agents. IUIS Committee on Primary Immunodeficiency Disease. International Union of Immunological Societies.免疫球蛋白替代疗法与潜在可传播病原体相关的安全性和可及性。国际免疫学会原发性免疫缺陷病委员会。国际免疫学会联盟。
Clin Exp Immunol. 1999 Oct;118 Suppl 1(Suppl 1):29-34. doi: 10.1046/j.1365-2249.1999.00000.x.